BioSig Technologies

BSGM70

High Growth

$2.00arrow_drop_up3.36%$0.06

High Growth

Penny Stock

BSGM70

$2.00

arrow_drop_up3.36%$0.06

High Growth

Penny Stock

Performance History

Key Stats
Open	$1.96
Prev. Close	$1.93
EPS	-1.34
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$34.46M
PE Ratio	-

	LOW	HIGH
Day Range	1.81	2.10
52 Week Range	0.20	6.80

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-1.34

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About BioSig Technologies (BSGM)

BioSig Technologies Inc (BSGM) is a medical technology company focused on improving the diagnosis and treatment of cardiac arrhythmias. The company’s flagship product is the PURE EP System, which is designed to enhance the capabilities of electrophysiology (EP) labs. The PURE EP System is a non-invasive, real-time signal acquisition and processing system that provides high-fidelity cardiac signals with minimal interference. By improving the quality of EP recordings, the system aims to help healthcare professionals achieve more accurate diagnoses and better treatment outcomes for patients with cardiac arrhythmias.

BioSig Technologies Inc has a history of innovation and has made significant progress in advancing the field of electrophysiology. The company has obtained numerous patents for its technology and has established partnerships with leading medical institutions and healthcare providers. The PURE EP System has been successfully tested in clinical trials and has received positive feedback from both doctors and patients.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Mr. Kenneth L. Londoner M.B.A., MBA
Headquarters: Westport
Employees: 47
Exchange: NASDAQ

Keep an eye on BioSig Technologies

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is BioSig Technologies 's (BSGM) price per share?

The current price per share for BioSig Technologies (BSGM) is $2. The stock has seen a price change of $0.07 recently, indicating a 3.37% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for BioSig Technologies (BSGM)?

For BioSig Technologies (BSGM), the 52-week high is $6.8, which is 240% from the current price. The 52-week low is $0.2, the current price is 895.02% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is BioSig Technologies (BSGM) a growth stock?

BioSig Technologies (BSGM) has shown an average price growth of -4.13% over the past three years. It has received a score of 94 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying BioSig Technologies as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is BioSig Technologies (BSGM) stock price performance year to date (YTD)?

As of the latest data, BioSig Technologies (BSGM) has a year-to-date price change of -53.81%. Over the past month, the stock has experienced a price change of 198.51%. Over the last three months, the change has been 400%. Over the past six months, the figure is 24.22%. Looking at a longer horizon, the five-year price change stands at -96.85%.

help

Is BioSig Technologies (BSGM) a profitable company?

BioSig Technologies (BSGM) has a net income of -$28.69M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -40.71K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$28.51M. Furthermore, the EBITDA is -$18.38M.

help

What is the market capitalization of BioSig Technologies (BSGM)?

BioSig Technologies (BSGM) has a market capitalization of $34.47M. The average daily trading volume is 1.96, indicating the stock's liquidity and investor engagement.

News

COMPANY ANNOUNCEMENT

DIRECTORS AND OFFICERS

Jun 10, 2024

BioSig Technologies Appoints Mr. Ferdinand Groenewald to Position of Interim Chief Financial Officer and Principal Accounting Officer

COMPANY ANNOUNCEMENT

May 21, 2024

BioSig Technologies Chief Executive Officer Mr. Anthony Amato Issues the Following Letter to Shareholders

DIRECTORS AND OFFICERS

COMPANY ANNOUNCEMENT

May 3, 2024

BioSig Technologies, Inc. Announces New Appointments to its Now Fully Constituted Board of Directors, which is Comprised of 5 Board Members, 3 Independent

COMPANY ANNOUNCEMENT

DIRECTORS AND OFFICERS

MANAGEMENT CHANGES

Apr 30, 2024

BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately